138 related articles for article (PubMed ID: 31442042)
1. Study of SHMT2 Inhibitors and Their Binding Mechanism by Computational Alanine Scanning.
He L; Bao J; Yang Y; Dong S; Zhang L; Qi Y; Zhang JZH
J Chem Inf Model; 2019 Sep; 59(9):3871-3878. PubMed ID: 31442042
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.
Scaletti E; Jemth AS; Helleday T; Stenmark P
FEBS Lett; 2019 Jul; 593(14):1863-1873. PubMed ID: 31127856
[TBL] [Abstract][Full Text] [Related]
3. Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming.
Paiardini A; Tramonti A; Schirch D; Guiducci G; di Salvo ML; Fiascarelli A; Giorgi A; Maras B; Cutruzzolà F; Contestabile R
Biochim Biophys Acta; 2016 Nov; 1864(11):1506-17. PubMed ID: 27530298
[TBL] [Abstract][Full Text] [Related]
4. Identification of three new compounds that directly target human serine hydroxymethyltransferase 2.
Han Y; He L; Qi Y; Zhao Y; Pan Y; Fang B; Li S; Zhang JZH; Zhang L
Chem Biol Drug Des; 2021 Feb; 97(2):221-230. PubMed ID: 32779873
[TBL] [Abstract][Full Text] [Related]
5. A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells.
Marani M; Paone A; Fiascarelli A; Macone A; Gargano M; Rinaldo S; Giardina G; Pontecorvi V; Koes D; McDermott L; Yang T; Paiardini A; Contestabile R; Cutruzzolà F
Oncotarget; 2016 Jan; 7(4):4570-83. PubMed ID: 26717037
[TBL] [Abstract][Full Text] [Related]
6. Human Cytosolic and Mitochondrial Serine Hydroxymethyltransferase Isoforms in Comparison: Full Kinetic Characterization and Substrate Inhibition Properties.
Tramonti A; Nardella C; di Salvo ML; Barile A; Cutruzzolà F; Contestabile R
Biochemistry; 2018 Dec; 57(51):6984-6996. PubMed ID: 30500180
[TBL] [Abstract][Full Text] [Related]
7. Cancer proteome and metabolite changes linked to SHMT2.
Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes.
Tramonti A; Paiardini A; Paone A; Bouzidi A; Giardina G; Guiducci G; Magnifico MC; Rinaldo S; McDermott L; Menendez JA; Contestabile R; Cutruzzolà F
Arch Biochem Biophys; 2018 Sep; 653():71-79. PubMed ID: 29991441
[TBL] [Abstract][Full Text] [Related]
9. Alanine scanning combined with interaction entropy studying the differences of binding mechanism on HIV-1 and HIV-2 proteases with inhibitor.
Cong Y; Duan L; Huang K; Bao J; Zhang JZH
J Biomol Struct Dyn; 2021 Mar; 39(5):1588-1599. PubMed ID: 32100625
[TBL] [Abstract][Full Text] [Related]
10. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.
Wilke AC; Doebele C; Zindel A; Lee KS; Rieke SA; Ceribelli M; Comoglio F; Phelan JD; Wang JQ; Pikman Y; Jahn D; Häupl B; Schneider C; Scheich S; Tosto FA; Bohnenberger H; Stauder P; Schnütgen F; Slabicki M; Coulibaly ZA; Wolf S; Bojarczuk K; Chapuy B; Brandts CH; Stroebel P; Lewis CA; Engelke M; Xu X; Kim H; Dang TH; Schmitz R; Hodson DJ; Stegmaier K; Urlaub H; Serve H; Schmitt CA; Kreuz F; Knittel G; Rabinowitz JD; Reinhardt HC; Vander Heiden MG; Thomas C; Staudt LM; Zenz T; Oellerich T
Blood; 2022 Jan; 139(4):538-553. PubMed ID: 34624079
[TBL] [Abstract][Full Text] [Related]
11. Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs.
Minton DR; Nam M; McLaughlin DJ; Shin J; Bayraktar EC; Alvarez SW; Sviderskiy VO; Papagiannakopoulos T; Sabatini DM; Birsoy K; Possemato R
Mol Cell; 2018 Feb; 69(4):610-621.e5. PubMed ID: 29452640
[TBL] [Abstract][Full Text] [Related]
12. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
[TBL] [Abstract][Full Text] [Related]
13. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
[TBL] [Abstract][Full Text] [Related]
14. Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma.
Woo CC; Chen WC; Teo XQ; Radda GK; Lee PT
Oncotarget; 2016 Aug; 7(33):53005-53017. PubMed ID: 27391339
[TBL] [Abstract][Full Text] [Related]
15. The role of SHMT2 in modulating lipid metabolism in hepatocytes via glycine-mediated mTOR activation.
Choi YJ; Lee G; Yun SH; Lee W; Yu J; Kim SK; Lee BH
Amino Acids; 2022 May; 54(5):823-834. PubMed ID: 35212811
[TBL] [Abstract][Full Text] [Related]
16. Improved catalytic properties of a serine hydroxymethyl transferase from Idiomarina loihiensis by site directed mutagenesis.
Kumar A; Wu G; Wu Z; Kumar N; Liu Z
Int J Biol Macromol; 2018 Oct; 117():1216-1223. PubMed ID: 29727646
[TBL] [Abstract][Full Text] [Related]
17. Computational Alanine Scanning with Interaction Entropy for Protein-Ligand Binding Free Energies.
Liu X; Peng L; Zhou Y; Zhang Y; Zhang JZH
J Chem Theory Comput; 2018 Mar; 14(3):1772-1780. PubMed ID: 29406753
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
[TBL] [Abstract][Full Text] [Related]
19. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.
Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS
Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
Ji L; Tang Y; Pang X; Zhang Y
Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
